Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Adolescent Depression
Interventions
DRUG

Bifidobacterium

3 capsules, 3 times a day, for 8 consecutive weeks

DEVICE

High-frequency rTMS

"In the rTMS treatment, the transcranial magnetic stimulation device with an 8-shaped coil with a diameter of 70mm was placed on the dorsolateral area of the left prefrontal lobe of the patient. The motor threshold was set to 90%. A 10-Hz pulse sequence was applied for 4 secs followed by a 20 secs interval. 10 pulses per train were used, and the total stimulation time was 30mins per day, 4 times a week, for 8 consecutive weeks."

DRUG

Escitalopram Oxalate

Oral escitalopram oxalate. The initial dose was 5mg/d, for 7 consecutive days. The dose was increased to 10 mg/d according to the tolerance of the patients for another 7 consecutive days, and then to 20 mg/d according to the patient's condition and tolerance for 8 weeks

Trial Locations (1)

063003

Tangshan Workers' Hospital, Tangshan

All Listed Sponsors
lead

Zhen-Hong Hu

OTHER